BioWorld MedTech

May 31, 2017

View Archived Issues

Saluda Medical evokes funding from two industry heavyweights in series D round

Saluda Medical Pty Ltd. is spreading its roots in both the neuromodulation space and the developing bioelectronics medicine market with its latest funding round. Read More

Intuitive surges as robotic surgery acceptance settles in, but can it maintain momentum?

Read More

Ra Medical's laser ablative PAD treatment is now FDA-approved

Read More

FDA rejects Sunovion Pharmaceuticals' new drug app for COPD drug and nebulizer

Read More

Appointments and advancements

Read More

Other news to note

Read More

Financings

Read More

Product briefs

Read More

Medical Device Daily's Oncology Extra

Read More